These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 16540557

  • 21. Cardiovascular disease in chronic kidney disease.
    Saran AM, DuBose TD.
    Ther Adv Cardiovasc Dis; 2008 Dec; 2(6):425-34. PubMed ID: 19124439
    [Abstract] [Full Text] [Related]

  • 22. Oxidative stress and chronic kidney disease.
    Brown SA.
    Vet Clin North Am Small Anim Pract; 2008 Jan; 38(1):157-66, vi. PubMed ID: 18249247
    [Abstract] [Full Text] [Related]

  • 23. Altered regulation of renin-angiotensin, endothelin and natriuretic peptide systems in rat kidney with chronic unilateral ureteral obstruction.
    Bae EH, Kim IJ, Park JW, Ma SK, Choi KC, Lee JU, Kim SW.
    Urol Int; 2007 Jan; 79(2):170-6. PubMed ID: 17851289
    [Abstract] [Full Text] [Related]

  • 24. The endothelin system and endothelin receptor antagonists.
    Jandeleit-Dahm KA, Watson AM.
    Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):66-71. PubMed ID: 22123210
    [Abstract] [Full Text] [Related]

  • 25. Oxidative stress in uremia: the role of anemia correction.
    Lahera V, Goicoechea M, de Vinuesa SG, Oubiña P, Cachofeiro V, Gómez-Campderá F, Amann R, Luño J.
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S174-7. PubMed ID: 17130258
    [Abstract] [Full Text] [Related]

  • 26. [Early diagnosis of chronic kidney disease. New insights into creatinine and proteinuria].
    Brandenburg V, Floege J.
    Med Klin (Munich); 2006 Mar 22; 101 Suppl 1():158-62. PubMed ID: 16802544
    [Abstract] [Full Text] [Related]

  • 27. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
    Balamuthusamy S, Srinivasan L, Verma M, Adigopula S, Jalandhara N, Hathiwala S, Smith E.
    Am Heart J; 2008 May 22; 155(5):791-805. PubMed ID: 18440325
    [Abstract] [Full Text] [Related]

  • 28. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

  • 29. Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence.
    Neuhofer W, Pittrow D.
    Eur J Clin Invest; 2009 Jun 20; 39 Suppl 2():50-67. PubMed ID: 19335747
    [Abstract] [Full Text] [Related]

  • 30. Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease.
    Fujii H, Nakai K, Fukagawa M.
    Ther Apher Dial; 2011 Apr 20; 15(2):125-8. PubMed ID: 21426501
    [Abstract] [Full Text] [Related]

  • 31. Aldosterone is a major factor in the progression of renal disease.
    Ibrahim HN, Rosenberg ME, Greene EL, Kren S, Hostetter TH.
    Kidney Int Suppl; 1997 Dec 20; 63():S115-9. PubMed ID: 9407437
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD.
    Agarwal R.
    Clin J Am Soc Nephrol; 2009 Sep 20; 4(9):1523-8. PubMed ID: 19478099
    [Abstract] [Full Text] [Related]

  • 34. Endothelin: a mediator of renal disease progression.
    Bruzzi I, Remuzzi G, Benigni A.
    J Nephrol; 1997 Sep 20; 10(4):179-83. PubMed ID: 9377723
    [Abstract] [Full Text] [Related]

  • 35. New insights on inflammation in chronic kidney disease-genetic and non-genetic factors.
    Stenvinkel P.
    Nephrol Ther; 2006 Jul 20; 2(3):111-9. PubMed ID: 16890135
    [Abstract] [Full Text] [Related]

  • 36. Antihypertensive agents and arterial stiffness: relevance to reducing cardiovascular risk in the chronic kidney disease patient.
    Agarwal R.
    Curr Opin Nephrol Hypertens; 2007 Sep 20; 16(5):409-15. PubMed ID: 17693754
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The renoprotective effects of RAS inhibition: focus on prevention and treatment of chronic kidney disease.
    Weir MR.
    Postgrad Med; 2009 Jan 20; 121(1):96-103. PubMed ID: 19179817
    [Abstract] [Full Text] [Related]

  • 39. [Hypertension and renal disease].
    Kamper AL, Pedersen EB, Strandgaard S.
    Ugeskr Laeger; 2009 Jun 15; 171(25):2109-13. PubMed ID: 19671393
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.